You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
魯抗醫藥(600789.SH):子公司藥品硝苯地平緩釋片(I)通過仿製藥一致性評價
格隆匯 09-07 17:35

格隆匯9月7日丨魯抗醫藥(600789.SH)公佈,公司控股子公司山東魯抗醫藥集團賽特有限責任公司(以下簡稱“賽特公司”)收到國家藥品監督管理局頒發的關於硝苯地平緩釋片(I)(以下簡稱“該藥品”)通過仿製藥質量和療效一致性評價的《藥品補充申請批准通知書》(批件號:2023B04371)。

硝苯地平緩釋片(I)是治療原發性高血壓的一線首選用藥,屬於鈣通道阻滯藥,可阻滯鈣離子經過心肌或血管平滑肌細胞膜上的通道進入細胞內,通過干擾鈣離子內流,降低細胞內鈣離子水平,從而改變心肌收縮性和血管張力,減低全身血管張力,擴張血管,降低血壓,適用於多種類型的高血壓,對頑固性、重度高血壓也有較好的療效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account